SELLAS Life Sciences Group, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2017
Total Assets: $33.5M
Liabilities Breakdown FY2017
Total Liabilities: $31.5M
Asset Breakdown
Total Assets: $33.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $2.3M | 6.9% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $1.9M | 5.7% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $29.3M | 87.4% |
Liabilities Breakdown
Total Liabilities: $31.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $11.7M | 37.2% |
| Long-Term Debt | $2.6M | 8.3% |
| Other Liabilities | $17.2M | 54.5% |